27.09.2014 Views

Program - Society of Toxicology

Program - Society of Toxicology

Program - Society of Toxicology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

50 th Anniversary Annual Meeting and ToxExpo<br />

<strong>Program</strong> Description (Continued)<br />

Tuesday<br />

Abstract # Abstract #<br />

#1113 Poster Board Number.....................................441<br />

NRF2 ACTIVATION PROMOTES<br />

HYPERCHOLESTEROLEMIA AND<br />

GALLSTONE FORMATION. ​M. A. Paranjpe 1 ,<br />

Q. Cheng 1 , J. Moscovitz 1 , D. Ajay 1 , M. Yamamoto 2<br />

and A. Slitt 1 . 1 Biomedical and Pharmaceutical<br />

Sciences, University <strong>of</strong> Rhode Island, Kingston,<br />

RI and 2 Medical Biochemistry, Tohoku University,<br />

Sendai, Miyagi, Japan.<br />

#1114 Poster Board Number.....................................442<br />

NRF2 PROTECTS MOUSE LIVER<br />

FROM OXIDATIVE INJURY AND<br />

STEATOHEPATITIS INDUCED BY<br />

PERSISTENT ACTIVATION OF AHR. ​H. Lu<br />

and C. D. Klaassen. University <strong>of</strong> Kansas Medical<br />

Center, Kansas City, KS.<br />

#1115 Poster Board Number.....................................443<br />

TCDD EFFECTS ON HEPATIC LIPID<br />

COMPOSITION IN MICE. ​M. M. Angrish 1,2 ,<br />

B. D. Mets 2,3 , D. Wright 3 and T. R. Zacharewski 1,2,3 .<br />

1<br />

Genetics <strong>Program</strong>, Michigan State University, East<br />

Lansing, MI, 2 Center for Integrative <strong>Toxicology</strong>,<br />

Michigan State University, East Lansing, MI and<br />

3<br />

Biochemistry & Molecular Biology, Michigan State<br />

University, East Lansing, MI.<br />

#1116 Poster Board Number.....................................444<br />

PHARMACOLOGIC NRF2 ACTIVATION<br />

PROMOTES HYPERCHOLESTEROLEMIA<br />

IN MICE. ​J. Moscovitz, M. Paranjpe and A. Slitt.<br />

University <strong>of</strong> Rhode Island, Kingston, RI.<br />

#1117 Poster Board Number.....................................445<br />

BERBERINE INDUCES HEPATIC<br />

STEATOSIS VIA C/EBPβ ACTIVATION. ​B.<br />

Lee 1 , Y. Choi 1 , H. Suh 1 , S. Jeoung 1 and K. Lee 2 .<br />

1<br />

Seoul National University, Seoul, Republic <strong>of</strong> Korea<br />

and 2 Sungkyunkwan University, Suwon, Republic<br />

<strong>of</strong> Korea.<br />

#1118 Poster Board Number.....................................446<br />

EFFECTS OF MEDICINAL HERBS<br />

AND THEIR COMPONENTS ON THE<br />

STEATOGENIC HEPATOTOXICITY. ​Y.<br />

Choi 1 , S. Jeoung 1 , H. Suh 1 , H. Choi 1 , S. Park 1 , S.<br />

Oh 1 , J. Choi 2 , S. Lee 3 , K. Lee 4 and B. Lee 1 . 1 Seoul<br />

National University, Seoul, Republic <strong>of</strong> Korea,<br />

2<br />

Pukyong National University, Pusan, Republic <strong>of</strong><br />

Korea, 3 Yeungnam University, Gyeongbuk, Republic<br />

<strong>of</strong> Korea and 4 Sungkyunkwan University, Suwon,<br />

Republic <strong>of</strong> Korea.<br />

#1119 Poster Board Number.....................................447<br />

FIBRINOGEN DEFICIENCY INCREASES<br />

LIVER INJURY AND EARLY GROWTH<br />

RESPONSE-1 EXPRESSION IN A MODEL<br />

OF CHRONIC XENOBIOTIC-INDUCED<br />

CHOLESTASIS. ​J. P. Luyendyk 1 , K. M. Kassel 1 ,<br />

K. Allen 1 , G. L. Guo 1 , G. Li 1 , G. H. Cantor 2 and<br />

B. L. Copple 1 . 1 Pharmacology, <strong>Toxicology</strong>, and<br />

Therapeutics, The University <strong>of</strong> Kansas Medical<br />

Center, Kansas City, KS and 2 Discovery <strong>Toxicology</strong>,<br />

Bristol-Myers Squibb, Princeton, NJ.<br />

#1120 Poster Board Number.....................................448<br />

ENDOGENOUS CYP1B1 METABOLISM IN<br />

VIVO CONTROLS ENDOGENOUS LIVER<br />

PPAR ACTIVITY WITHOUT EXPRESSION<br />

IN HEPATOCYTES. ​J. R. Bushk<strong>of</strong>sky 1,2 ,<br />

M. L. Larsen 3 , S. Wang 3 and C. R. Jefcoate 1,2,3 .<br />

1<br />

Endocrinology and Reproductive Physiology,<br />

University <strong>of</strong> Wisconsin Madison School <strong>of</strong><br />

Medicine and Public Health, Madison, WI,<br />

2<br />

Molecular and Environmental <strong>Toxicology</strong> Center,<br />

University <strong>of</strong> Wisconsin Madison, Madison, WI<br />

and 3 Department <strong>of</strong> Pharmacology, University <strong>of</strong><br />

Wisconsin Madison, Madison, WI.<br />

Tuesday Morning, March 8<br />

9:00 AM to 12:30 PM<br />

Exhibit Hall<br />

Poster Session: Ah Receptor in Immune Regulation and<br />

Toxicity<br />

Chairperson(s): Qing Li, Nippon Medical School, Tokyo, Japan.<br />

Displayed: 9:00 AM–12:30 PM<br />

Author Attended: 9:00 AM–11:00 AM<br />

#1121 Poster Board Number.....................................501<br />

EVIDENCE OF AhR-DEPENDENT<br />

SUPPRESSION OF IMMUNOGLOBULIN<br />

EXPRESSION. ​M. J. Wourms and C. Sulentic.<br />

Pharmacology and <strong>Toxicology</strong>, Boonsh<strong>of</strong>t School <strong>of</strong><br />

Medicine Wright State University, Dayton, OH.<br />

#1122 Poster Board Number.....................................502<br />

TCDD-INDUCED MODULATION OF THE<br />

hs1, 2 ENHANCER WITHIN THE 3’IgHRR<br />

IN MOUSE AND HUMAN. ​J. Liu, T. Fernando,<br />

S. Ochs and C. E. Sulentic. Pharmacology and<br />

<strong>Toxicology</strong>, Boonsh<strong>of</strong>t School <strong>of</strong> Medicine, Wright<br />

State Unversity, Dayton, OH.<br />

#1123 Poster Board Number.....................................503<br />

PAX5 MAY MEDIATE TCDD-INDUCED<br />

DIFFERENCES IN TRANSCRIPTIONAL<br />

REGULATION OF THE MOUSE AND<br />

HUMAN hs1, 2 ENHANCER. ​S. Ochs, J. Liu and<br />

C. Sulentic. Pharmacology and <strong>Toxicology</strong>, Wright<br />

State Unversity, Dayton, OH.<br />

#1124 Poster Board Number.....................................504<br />

ROLE OF THE 3’IgHRR IN TCDD-<br />

INDUCED SUPPRESSION OF THE<br />

IMMUNOGLOBULIN HEAVY CHAIN. ​J. L.<br />

Panchal, E. Romer, T. Fernando and C. Sulentic.<br />

Pharmacology and <strong>Toxicology</strong>, Boonsh<strong>of</strong>t School <strong>of</strong><br />

Medicine, Wright State University, Dayton, OH.<br />

#1125 Poster Board Number.....................................505<br />

NF-B/REL AND THE AhR IN MODULATING<br />

THE 3́IgHRR. ​R. Salisbury and C. Sulentic.<br />

Pharmacology and <strong>Toxicology</strong>, Boonsh<strong>of</strong>t School <strong>of</strong><br />

Medicine, Wright State University, Dayton, OH.<br />

#1126 Poster Board Number.....................................506<br />

PERSISTENT DEVELOPMENTAL<br />

ARYLHYDROCARBON RECEPTOR<br />

ACTIVATION MODULATES NOTCH1-<br />

DEPENDENT T-CELL BUT NOT B-CELL<br />

DIFFERENTIATION POTENTIAL. ​L.<br />

Ahrenhoerster, P. Lakatos and M. Laiosa. School <strong>of</strong><br />

Public Health, University <strong>of</strong> Wisconsin Milwaukee,<br />

Milwaukee, WI.<br />

214<br />

Education-Career Development Sessions<br />

Exhibitor Hosted Sessions<br />

Featured Sessions<br />

Historical Highlights<br />

Informational Sessions<br />

Platform Sessions

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!